TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ASMB

Assembly Biosciences Inc

Healthcare · Biotechnology

22.80$ -0.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ASMB
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – 20.6% -438.8% -526.6% -79.6% -1,493.4% – 317.5% -179.2% -56.8%
– – – – – – – – – 2.4% 4.3% 3.1% 0.9% 7.5% – 6.3% 0.5% 0.2%
– – – – – – – – – 95.4% 192.4% 128.8% 27.6% 83.7% – 71.5% 10.9% 6.5%
– – – – – – – – – 1.8% 199.8% 152.4% 36.4% 757.8% – – – –
– – – – – – – – – 491.0% -28.4% -59.7% -38.3% -182.3% – 1,065.8% -41.9% -52.9%
– – – – – – – – – 9.6% 2.3% 9.7% 2.8% 49.5% – 3.6% 0.1% 0.1%
– – – – – – – – – -173.4% -914.6% -315.2% 86.1% 424.0% – -965.2% 140.9% -156.9%
– – – – – – – – – 0.0% – – – – – – – –
– – – – – – – – – 745.6% 1,079.4% 874.8% 9.6% – – – – –
– – – – – – – – – 745.6% 1,079.4% 874.8% 9.6% 848.5% – 192.9% 103.3% 241.6%
– – – – – – – – – 592.7% -274.0% 33.0% 16.1% -220.9% – -454.8% 64.9% 27.8%
– – – – – – – – – 11.0% -441.1% -536.4% -82.4% -1,542.9% – 313.9% -179.3% -56.9%

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?